Broker's call: Eris Lifesciences (Buy)
Motilal Oswal FinancialEris Lifesciences (Buy)Target: 870CMP: 733.05We initiate coverage on Eris Lifesciences (ERIS) with a Buy rating and a target29-12-2021
29-12-2021
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING22-12-2021
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING22-12-2021
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares pursuant to ESOP-2017 Scheme21-12-2021
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
TRANSCRIPT OF ANALYST AND INVESTOR CALL09-12-2021
Analyst Call: Eris Lifesciences Joint Venture with MJ Biopharm
Conference Call with Eris Lifesciences Management and Analysts on its joint venture announcement with MJ Biopharm. Listen to the full transcript.07-12-2021
Earnings Call for Q2FY22 of Eris Lifesciences
Conference Call with Eris Lifesciences Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.06-12-2021
Buy Eris Lifesciences; target of Rs 954: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 954 in its research report dated December 06, 2021.06-12-2021
Eris Lifesciences forms JV with MJ Biopharm to enter India's insulin segment
The 70:30 JV will primarily engage in marketing and distribution of Human and Analogue Insulin including Aspart, Glargine and Lispro and GLP-1 agonists.03-12-2021
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL03-12-2021